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E-mail: saltoglu.nese@gmail.comIntroductionDiabetes mellitus (DM) is a common chronic disease that has
become a global health problem with an alarming increase in
incidence [1]. In Turkey, the prevalence of DM has been re-
ported as 7.2%, indicating approximately ﬁve million patients
with the disease [2]. Among different complications, diabetic
foot infection (DFI) is a signiﬁcant cause of morbidity and
mortality among patients with diabetes and has a life-time
incidence of 4–7% [3]. It is one of the primary reasons for
diabetes-related hospitalizations and limb loss [4]. Infection in
diabetic foot ulcers may progress rapidly and often leads to
lower limb amputation so it is critical to determine the pres-
ence of infection [5]. Timely diagnosis, early identiﬁcation of the
need for hospitalization and institution of proper patient
monitoring protocols are important for follow up and survival
of the patients. Adequate antimicrobial therapy should be
started as early as possible based on criteria such as possible
pathogens, depth of the infection, presence of ischaemia and
presence of any systemic symptoms [6].
Here we report a multicentre observational retrospective
study. Our objective was to investigate the predictors for limb
loss among patients with diabetes who have skin/soft-tissue
infections and osteomyelitis.Patients and methodsIn this retrospective observational study, consecutive patients
with DFI from 17 centres in Turkey were included between 15
May 2011 and 30 May 2013. All the inpatients and outpatients
were followed up and assessed by members of the Turkish
Diabetic Foot Study Group of the Turkish Society of Clinical
Microbiology and Infectious Diseases.
Infection was diagnosed clinically by a trained physician ac-
cording to the validated system for infection severity deﬁned by
the International Working Group on the Diabetic Foot (also
abbreviated as Diabetic Foot) PEDIS classiﬁcation. A DFI
severity score was determined as mild, moderate or severe
following the guidelines of the Infectious Diseases Society of
America. Accordingly, patients were also identiﬁed by clinicalnical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectdescription for soft-tissue infection (cellulitis, infected ulcer,
necrotizing infection) or osteomyelitis [7]. All patients with
severe infection, selected patients with a moderate infection
with complicating features, and any patient unable to comply
with the required outpatient regimen for psychological or social
reasons were hospitalized initially. Specimens for culture
included samples from deep tissue obtained by biopsy or
curettage after the wound had been cleansed and debrided.
Wound swabs were avoided. The following patient information
was recorded using a structured electronic form: age, sex,
duration of diabetes, diabetes type and type of diabetic treat-
ment, presence of chronic renal failure, cardiac failure, reti-
nopathy, history of dialysis, history of previous foot infection,
hospital admissions, medical and surgical treatments, history of
amputation and presenting complaints, infection severity, time
spent before hospitalization, microorganisms and antimicrobial
resistance, clinical and laboratory ﬁndings, diagnostic pro-
cedures used, antimicrobial and other treatments and treat-
ment outcomes for the current admission.
The primary outcome was limb loss. Deﬁnition of limb loss
includes toe amputation, metatarsal (ray) amputation, below-
knee amputation (BKA) and above-knee amputation (AKA).
Both BKA and AKA were considered as major amputations. In
our study, the decision for amputation was taken by the Dia-
betic Foot Council of the respective hospitals. The patients
were followed up after the operations by regular visits. Dura-
tion of follow up was 3–6 months.
An independent professional data manager from a Contract
Research Organization (CRO) visited the centres and recorded
the data into an electronic form.
The study was approved by the Ethical Committee of
Cerrahpas¸a Medical Faculty of Istanbul University.
Statistical analysis
For comparison of continuous variables a Kruskal–Wallis test
was performed, and for categorical variables a chi-square test
was performed. Multivariate analysis was performed for
detection of the predictors of limb loss. The independent var-
iables for multivariate analysis were selected according to sta-
tistical signiﬁcance in univariate analysis, collinear variables
were excluded. The performance of multivariate analysis was
estimated by calculation of the area under the receiver oper-
ating characteristics curve, and compared with the performance
of a previously published model (4). All the patients were
scored according to an already deﬁned risk score (4), and the
score performance was assessed. Statistical signiﬁcance was set
as p < 0.05, and STATA (version 11; StataCorp, College Station,
TX, USA) was used.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 659–664
TABLE 1. Demographic characteristics, risk factors, and
comordities of patients related to limb loss
Limb loss
(n [ 126)
No limb loss
(n [ 329) p
Demographic characteristics
Male gender, n (%) 96 (76) 214 (65) 0.022
Median age (IQR) 62 (57–70) 61 (54–69) 0.113
Age 50 years, n (%) 119 (94) 279 (85) 0.005
Diabetes mellitus, type II, n (%) 126 (100) 326 (99) NA
Insulin use 112 (89) 239 (73) <0.001
Risk factors
Median DM duration (years, IQR) 19 (10–25) 14 (7–20) 0.001
Median body mass index (IQR) 28 (25–29) 28 (25–31) 0.198
History of hospitalization, n (%) 95 (75) 202 (61) 0.005
History of recurrent infection, n (%) 9 (7) 26 (8) 0.785
History of osteomyelitis, n (%) 46 (37) 75 (23) 0.003
History of debridement, n (%) 54 (43) 101 (31) 0.014
History of amputation, n (%) 43 (34) 67 (20) 0.002
History of current smoking, n (%) 40 (32) 84 (26) 0.183
History of vascular surgery, n (%) 20 (16) 51 (16) 0.922
Antibiotic use within the last 30
days, n (%)
73 (58) 164 (50) 0.122
Nasal carriage of Staphylococcus
aureus, n (%)
2 (1.5) 11 (3.3) 0.314
Rate of methicillin-resistant
Staphylococcus aureus, n (%)
2 (1.5) 5 (1.5) 0.958
Dialysis, n (%) 18 (14) 32 (10) 0.164
Comorbidities
Chronic renal disease, n (%) 43 (34) 79 (24) 0.029
Coronary artery disease, n (%) 26 (21) 46 (14) 0.082
Retinopathy, n (%) 25 (20) 32 (10) 0.004
CMI Saltoglu et al. Limb loss predictors in diabetic foot infections 661ResultsAmong 455 DFI patients treated in 17 centres during the study
period, 310 (68%) were male. Median age of the patients was 61TABLE 2. Characteristics of infection according to limb loss
Limb loss
(n [ 126)
No limb loss
(n [ 329) p
PEDIS Peripheral artery disease (PAD)*
Stage 1:No PAD sign, palpable dorsopedal
or posterior tibial artery, n (%)
41 (33) 193 (59) <0.001
Stage 2: Signs of PAD and claudication,
but no severe ischaemia, n (%)
51 (40) 96 (29) 0.021
Stage 3: Severe ischaemia, n (%) 32 (25) 31 (9) <0.001
Median wound width (cm2), (IQR) 6 (3–15) 6 (3–15) 0.313
Site of wound
Big toe, n (%) 57 (95) 83 (85) 0.048
Other toes, n (%) 60 (48) 73 (22) <0.001
Metatarsal, n (%) 49 (32) 54 (16) <0.001
Back foot, n (%) 17 (13) 49 (15) 0.704
Heel, n (%) 14 (11) 54 (16) 0.156
PEDIS Grade and IDSA infection severity score (*lit.7)
PEDIS Grade 2 (Mild infection) (%) 23 (18) 116 (35) <0.001
PEDIS Grade 3 (Moderate infection) (%) 77 (57) 191 (51) 0.553
PEDIS Grade 4 (Severe infection = SIRS)
(%)
26 (21) 22 (7) <0.001
Osteomyelitis (%) 73 (58) 48 (15) <0.001
Charcot joint (%) 4 (3) 10 (3) 0.227
Median day of hospitalization 30 (4–170) 17 (3–90) <0.001
Median leucocyte count (103 μ/L) 13,000 11,000 0.004
Median C-reactive protein level (mg/dl) 26 16 0.009
Median erythrocyte sedimentation rate
(mm/h) ±standard deviation
87 70 0.001
HA1C level > 7 (%) 94 (75) 236 (72) 0.539
Hyperbaric O2 therapy (%) 38 (30) 66 (20) 0.001
Outcome measures
Exitus (%) 7 (6) 15 (5) 0.658
Recurrent infection (%) 9 (7) 26 (8) 0.785
Re-hospitalization (%) 15 (12) 27 (8) 0.01
IDSA, Infectious Diseases Society of America.
*PEDIS stage, grade and severity of infection were determined according to the
literature [7].
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyyears, with a range of 29–90 years (Table 1). Seventy-ﬁve per
cent of the patients were hospitalized and 52% of the patients
had used antibiotics within the last month (Table 1). All the
patients with severe infection and 248 patients (88%) with
moderately severe infections were hospitalized. Among the
patients, 287 (63%) had complicated skin/soft-tissue infections,
and 121 (27%) had osteomyelitis. Peripheral arterial disease was
identiﬁed in 210 (46.1%) patients (Table 2).
In total, 208 microorganisms were isolated from 455 pa-
tients, 92 (44.2%) were Gram-positive cocci and 114 (54.8%)
were Gram-negative rods (GNR) (Table 3). Limb loss occurred
in 126 (28%) patients: amputation of the big toe in 35 (28%),
amputation of other toes in 32 (25%), ray amputation in 15
(12%), BKA in 31 (24%), and AKA in 13 (10%) patients. Of all
the amputations, one-third were major amputations. During
follow up, 32 (7%) patients required recurrent surgery and re-
infection occurred in 35 (7.7%) patients. The death rate during
follow up was 4.8% (22 patients). Length of hospital stay was 21
days (range: 3–170 days) for moderate DFI and 24 days
(3–120) for severe DFI (p 0.190).
On univariate analysis, history of amputation was more
common among the patients with limb loss (34% versus 20%, p
0.002, Table 1). Limb loss rates were higher for patients who
had osteomyelitis—with osteomyelitis 78 (61.9%) versus
without osteomyelitis 48 (38.1%), p < 0.001. BKA rates were
higher for patients with osteomyelitis compared with patients
with complicated skin/soft-tissue infection—osteomyelitis 12
(9.9%) versus skin/soft-tissue infection 14 (4.1%), p 0.020.
Leucocyte counts were signiﬁcantly higher in amputated
compared with non-amputated patients (13 000 versus 11 000,
respectively; p 0.004). We found signiﬁcantly high rates of GNR
(Escherichia coli and Psuedomonas aeruginosa) in amputated pa-
tients (p 0.02). Rates of limb loss were similar in patients from
whom extended-spectrum β-lactamase (ESBL) were isolatedTABLE 3. Microorganisms isolated from patients with diabetic
foot infection (n [ 208)
n (%)
Gram-negative bacteria 114 (54.8)
Pseudomonas aeruginosa 36 (17.3)
Escherichia coli 30 (14.4)
Enterobacter 11 (5.3)
Klebsiella 10 (4.8)
ESBL producing Enterobacteriaceae 10 (19.6)
Proteus 13 (4.8)
Acinetobacter 10 (4.8)
Morganella 4 (1.9)
Gram-positive bacteria 92 (44.2)
Methicillin-sensitive Staphylococcus aureus 37 (17.8)
Methicillin-resistant Staphylococcus aureus 11 (5.3)
Methicillin-resistant coagulase negative Staphylococcus 18 (8.6)
Streptococcus 14 (6.7)
Enterococcus 12 (5.8)
Anaerobic bacteria 2 (1)
and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 659–664
TABLE 4. Predictors of limb loss
Univariate analysis
Multivariate
analysis
OR 95% CI p OR 95% CI p
Chronic renal disease 1.64 1.05–2.56 0.03 0.84 0.5–1.41 0.520
Age >50 years 3 1.34–6.91 0.008 2.41 0.98–5.88 0.053
Male gender 1.71 1.07–2.74 0.023 1.75 1.04–2.96 0.034
Duration of DM > 20 years 2.3 1.53–3.54 <0.001 1.9 1.18–3.11 0.008
Infected ulcer versus cellulitis 2.6 1.61–4.16 <0.001 1.9 1.11–3.18 0.019
History of amputation 2 1.28–3.19 0.002 1.23 0.72–2.09 0.447
History of peripheral vascular
disease
3 1.99–4.71 <0.001 2 1.26–3.27 0.004
Retinopathy 2.29 1.29–4.06 0.004 2.25 1.19–4.25 0.012
Leucocyte count >11 000/mm3 1.8 1.16–2.67 0.008 1.4 0.88–2.25 0.150
Erythrocyte sedimentation rate
>70 mm/hr
1.75 1.13–2.71 0.011 1.6 1.01–2.68 0.05
Gram-negative bacteria 1.8 1.15–2.86 0.01 1.8 1.08–3.02 0.022
662 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIversus patients without ESBL. Rates of limb loss were similar in
patients undergoing dialysis (18/50) versus patients not under-
going dialysis (108/405), p 0.164.
On multivariate analysis, we found the following independent
parameters as signiﬁcant: male gender (OR 1.75, 95% CI
1.04–2.96, p 0.034), duration of DM > 20 years (OR 1.9, 95%
CI 1.18–3.11, p 0.008), infected ulcer versus cellulitis (OR 1.9,
95% CI 1.11–3.18, p 0.019), history of peripheral vascular
disease (OR 2, 95% CI 1.26–3.27, p 0.004), retinopathy (OR
2.25, 95% CI 1.19–4.25, p 0.012), erythrocyte sedimentation
rate >70 mm/h (OR 1.6, 95% CI 1.01–2.68, p 0.05), and
infection with Gram-negative bacteria (OR 1.8, 95% CI
1.08–3.02, p 0.02). (Table 4). The area under the receiver
operating characteristics curve was 0.754 (95% CI 0.7–0.8).
Another multivariate analysis was performed including the in-
dependent variables indicated by Lipsky et al. [4]. The inde-
pendent variables included were chronic renal disease, male
gender, age >50 years, history of amputation, leucocyte count
>11 000, peripheral vascular disease and infected ulcer versusFIG. 1. Distribution of the cases according to Lipsky et al.’s risk score
and limb loss rates.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectcellulitis. Out of these independent variables, age >50 years,
peripheral vascular disease and infected ulcer versus cellulitis
were found to signiﬁcantly predict limb loss. This model’s area
under the receiver operating characteristics curve was 0.722
(95% CI 0.67–0.77).
We scored our patients according to the scoring system
suggested by Lipsky et al. (4), and this scoring system revealed
good predictive performance of limb loss (Fig. 1).DiscussionDespite the improvements in diagnosis and management, DFI
remains a signiﬁcant challenge [8]. In this large cohort study
conducted in Turkey, we studied the predictors of limb loss
among inpatients and outpatients with DFI, and described the
bacteriological ﬁndings and clinical outcomes. On multivariate
analysis the following independent parameters were found to
be signiﬁcant for the prediction of limb loss: male gender,
duration of DM > 20 years, infected ulcer versus cellulitis,
history of peripheral artery disease, erythrocyte sedimenta-
tion rate >70 mm/h, and infection with Gram-negative bac-
teria. The predictive estimate of our model 0.754, 95% CI
0.7–0.8 was similar to that of a model suggested by Lipsky
et al., 0.722, 95% CI 0.67–0.77 [4].
Lipsky et al. suggested the following risk factors for lower
limb amputation in patients with diabetes: surgical site infection,
vasculopathy, amputation history and high leucocyte count >11
000/mm3 [4]. We added a few more variables to this suggested
model, such as erythrocyte sedimentation rate >70, Gram-
negative infection and retinopathy. In another study, a wound
severity score and leucocyte counts were found to be related
to wound infection [9]. Faglia et al. reported that major
amputation rates were higher for patients with white blood cell
count >10 000/mm3, dialysis and osteomyelitis [10]. In our
study, the majority of isolated pathogens (55%) were GNR. The
most frequently isolated GNR was P. aeruginosa followed by
E. coli. Pseudomonas aeruginosa has been previously reported as
the most common bacteria among patients with severe DFI in
Turkey [11,12]. One-third of E. coli isolated in our study were
ESBL positive. Recently, ESBL-producing Enterobactericeae spe-
cies have been reported as a global problem [13]. Therefore,
the presence of ESBL-producing bacteria should be considered
in Turkey and similar countries in the empiric treatment for
severe DFI.
Among the isolated bacteria 44% were found to be Gram-
positive. Approximately one-quarter of patients from whom
S. aureus was isolated were found to be methicillin-resistant.
Nather et al. [14] and Fejfarová et al. [15] found methicillin-
resistant Staphylococcus aureus (MRSA) to be one of theious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 659–664
CMI Saltoglu et al. Limb loss predictors in diabetic foot infections 663signiﬁcant predictors for limb loss. We did not ﬁnd MRSA to be
a predictive factor for limb loss, but MRSA was found to be
signiﬁcantly associated with recurrent surgery.
In our study, the majority of patients (87%) were aged >50
years and had been diabetic for a long time (mean 15 years).
Moreover we found that the duration of diabetes was one of
the predictive factors for limb loss. Our ﬁndings are in
agreement with some studies, such as those by Resnick et al.
[16] and Lehto et al. [17]; however, a few studies had different
ﬁndings [14,18]. Osteomyelitis negatively affects both the
outcome and the treatment of DFI. We found a signiﬁcant
association between osteomyelitis and overall and major
amputation, similar to Armstrong et al. [19]. However, we did
not include osteomyelitis in the multivariable model to avoid
collinearity. Duration of antibiotic treatment, length of hospital
stay, and the duration of infection before initiation of treatment
were longer in the 121 cases with osteomyelitis in our study
compared with other patients. Mutluoglu et al. compared pa-
tients with and without osteomyelitis; and found that length of
hospital stay and antibiotic treatment, time before initiation of
treatment and wound healing times were longer and more
surgical interventions were required for patients with osteo-
myelitis [20].
Often, the speciﬁc pathogen cannot be isolated in suspected
or probable osteomyelitis. One of the limitations of our study
regarded the diagnosis of osteomyelitis, which was based
mostly on clinical, laboratory and radiological imaging results.
Diagnosis was established by magnetic resonance imaging (99
patients), probe test (52 patients), three-dimensional bone
scintigraphy (seven patients), histopathological ﬁnding (six pa-
tients); bone culture rates (35 patients) were lower. Anaerobic
cultures were not sufﬁciently performed at the study centres.
Another limitation lies in the design of the current study, which
was retrospective. Therefore, we missed some individual pa-
rameters such as reasons for amputation. The strengths of our
multicentre study were the high number of participants and the
inclusion of both inpatients and outpatients. Also, all the pa-
tients were followed up by diabetic foot councils for about 3–6
months.ConclusionsFoot infections among patients with diabetes are increasing,
especially in the elderly population. DFIs result in potential
limb loss and fatal outcome. Emergence of antibiotic
resistance is a signiﬁcant problem in the treatment of DFI.
Multivariate analysis revealed that detection of Gram-negative
infections predicted the limb loss signiﬁcantly. Early diagnosis
and case management in DFI are crucial. Surveillance ofClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyisolates and their susceptibility proﬁle should be monitored.
The management of patients should be optimized. Follow up
of the patients by diabetic foot councils would be useful to
decrease the rate of amputation. To promote this, our
research group initiated a multidisciplinary national guide for
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